CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
about
Maraviroc: a review of its use in HIV infection and beyondRegional but fatal: Intraperitoneal metastasis in gastric cancerLack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation.The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines.The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer.CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells.CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.C-C motif chemokine receptors in gastric cancer.Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
P2860
Q26778504-0FE6FE92-A004-4F0E-8528-2507482262AEQ28067269-43572BE8-26B0-417D-A186-8E766A19C500Q35755674-D80E3C9D-28E5-410C-8AC9-3E73194CCE89Q36309612-6E62E3CA-590F-462E-9F14-3BF476985616Q37565466-8B1DA0E5-F869-4454-8F4B-4A4E95DA253AQ37641553-C5B1EE98-7A61-4DC6-B7D0-A68443F8BD9CQ38855227-BC86C3B7-9B02-48E7-A47C-9F3D8C3BCE81Q38891169-2FCB9BAB-5692-4968-B4B6-56E621BC298EQ39223523-A33BC227-AA95-4DB7-B616-0CCA503B420BQ39236911-2AEFBE37-FE2E-40B5-B503-2B87EAEB5534Q47163024-B980F515-5ED6-4EF8-A5E4-53A977D4F404Q55021572-21DC750B-9520-4922-9D46-30B93311126C
P2860
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
@en
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
@nl
type
label
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
@en
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
@nl
prefLabel
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
@en
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.
@nl
P2093
P2860
P356
P1476
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination
@en
P2093
Andrea Mencarelli
Angela Bruno
Annibale Donini
Barbara Renga
Daniela Francisci
Franco Baldelli
Luigina Graziosi
Sabrina Cipriani
Stefano Fiorucci
P2860
P304
P356
10.1593/TLO.13499
P577
2013-12-01T00:00:00Z